Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium
Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium
复制标题
DOI:
10.1164/rccm.200408-1108oc
复制
发表时间:
2005-04-01
影响因子:
24.7
通讯作者:
Tesfaigzi, Y
中科院分区:
文献类型:
--
作者:
Harris, JF;Fischer, MJ;Tesfaigzi, Y
Bcl-2, an inhibitor of apoptosis, is expressed in LPS-induced metaplastic goblet cells of rat airways. The present study investigated expression of Bcl-2 in airway mucous cells of persons with cystic fibrosis and tested in rats and mice whether its expression is responsible for sustaining metaplastic mucous cells. A significantly higher percentage of mucous cells expressed Bcl-2 in humans with cystic fibrosis compared with control subjects with no disease or subjects with other diseases. In LIPS-instilled F344/N rats, the percentage of Bcl-2-positive mucous cells was decreased to background levels before the resolution of goblet cell metaplasia. Furthermore, intraperitoneal injection of rats with antisense oligonucleoticles significantly reduced Bcl-2 expression and goblet cell metaplasia in nasal and pulmonary airway epithelia in rats. In contrast, sustained expression of Bcl-2 in transgenic mice by a metallothionein promoter caused increased LPS-incluced goblet cell metaplasia over 8 days compared with wild-type mice. These studies demonstrate that BcI-2 expression sustains goblet cell metaplasia in various species, that epithelial cell numbers are directly linked to the regulation of the numbers of goblet cells, and that downregulating Bcl-2 expression reduces goblet cell metaplasia.